2007
DOI: 10.1158/0008-5472.can-07-2057
|View full text |Cite
|
Sign up to set email alerts
|

Cooperative Interactions between Androgen Receptor (AR) and Heat-Shock Protein 27 Facilitate AR Transcriptional Activity

Abstract: Androgen receptor (AR) transactivation is known to enhance prostate cancer cell survival. However, the precise effectors by which the prosurvival effects of androgen and AR drive prostate cancer progression are poorly defined. Here, we identify a novel feed-forward loop involving cooperative interactions between ligand-activated AR and heat-shock protein 27 (Hsp27) phospho-activation that enhance AR stability, shuttling, and transcriptional activity, thereby increasing prostate cancer cell survival. Androgen-b… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

17
200
1
2

Year Published

2009
2009
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 221 publications
(221 citation statements)
references
References 44 publications
17
200
1
2
Order By: Relevance
“…Additionally, 17-N-Allylamino-17-demethoxygeldanamycin (17-AAG); retaspimycin hydrochloride (IPI-504), two Hsp90 inhibitors, provided no benefit to CRPC patients (55,56). The poor therapeutic effect of Hsp90 inhibitors may be the consequence of inhibiting widespread client proteins and may thereby result in activation of oncogenic signaling pathways such as Src and co-chaperone Hsp27 up-regulation (57,58). Inhibition of Cdc37, a co-chaperone of Hsp90 that is overexpressed in cancer cells, may represent a better drug target in cancers (59).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, 17-N-Allylamino-17-demethoxygeldanamycin (17-AAG); retaspimycin hydrochloride (IPI-504), two Hsp90 inhibitors, provided no benefit to CRPC patients (55,56). The poor therapeutic effect of Hsp90 inhibitors may be the consequence of inhibiting widespread client proteins and may thereby result in activation of oncogenic signaling pathways such as Src and co-chaperone Hsp27 up-regulation (57,58). Inhibition of Cdc37, a co-chaperone of Hsp90 that is overexpressed in cancer cells, may represent a better drug target in cancers (59).…”
Section: Discussionmentioning
confidence: 99%
“…20,21) Taking this together with the results presented in Fig. 1, we hypothesized that HSP27 acts as a molecular chaperone for annexin II in resistance to UVC-induced cell death, thus regulating annexin II expression after UVC irradiation.…”
Section: Resultsmentioning
confidence: 73%
“…21) In the AP r -1 cells, the formation of a complex between HSP27 and annexin II increased in the nuclear fraction after UVC irradiation. 12) Annexin II is reported to function mainly in the cytoplasm, 13) but part of the protein localizes to and functions in the nucleus.…”
Section: Resultsmentioning
confidence: 92%
See 1 more Smart Citation
“…3 Consistent with this concept, targeting of HSPs and kinases in preclinical models inhibits AR function and PCa tumor growth. 4,5 While these diverse resistance mechanisms highlight the reliance of PCa on AR signaling, there is a critical need to identify therapeutic targets that regulate AR function as well as key downstream effector pathways.…”
mentioning
confidence: 99%